Probable tramadol-induced atypical serotonin syndrome in a patient receiving selective serotonin reuptake inhibitor and stopped at 10 days before surgery -A case report-
Anesthesia and Pain Medicine 2014³â 9±Ç 2È£ p.115 ~ p.118
°À¯(Kang Yoo) - Myongji Hospital Department of Anesthesiology and Pain Medicine
¹ÎÁøÇý(Min Jin-Hye) - Myongji Hospital Department of Anesthesiology and Pain Medicine
俵±Ù(Chae Young-Keun) - Myongji Hospital Department of Anesthesiology and Pain Medicine
ÀÌ»óÀº(Lee Sang-Eun) - Myongji Hospital Department of Anesthesiology and Pain Medicine
Á¦ÀÇÁø(Je Ui-Jin) - Myongji Hospital Department of Anesthesiology and Pain Medicine
ÀÌ¿ë°æ(Lee Yong-Kyung) - Myongji Hospital Department of Anesthesiology and Pain Medicine
Abstract
Tramadol can increase the serum level of serotonin, causing serotonin syndrome, which is a potentially life-threatening condition. Serotonin syndrome occurs when tramadol is used in combination with other drugs that affect serotonin. A patient who had been taking selective serotonin reuptake inhibitor and stopped at 10 days before surgery experienced intermittent heart rate elevation, tremor of the upper extremities and mental change after receiving an infusion of tramadol for postoperative pain control. Although he did not show the typical triad of serotonin syndrome (systemic autonomic dysfunction, neuromuscular impairment and mental status change), the patient was suspected to have serotonin syndrome caused by tramadol.
Å°¿öµå
Postoperative pain control, Selective serotonin reuptake inhibitors, Serotonin syndrome, Tramadol
KMID :
1155520140090020115
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸
À¯È¿¼º°á°ú(Recomendation)